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Abstract: Cell adhesion molecules (CAMs) play a pivotal role in the development and maintenance of the nervous system under normal 
conditions. They also are involved in numerous pathological processes such as inflammation, degenerative disorders, and cancer, making 
them attractive targets for drug development. The majority of CAMs are signal transducing receptors. CAM-induced intracellular signal-
ling is triggered via homophilic (CAM-CAM) and heterophilic (CAM - other counter-receptors) interactions, which both can be targeted 
pharmacologically. We here describe the progress in the CAM pharmacology focusing on cadherins and CAMs of the immunoglobulin 
(Ig) superfamily, such as NCAM and L1. Structural basis of CAM-mediated cell adhesion and CAM-induced signalling are outlined. Dif-
ferent pharmacological approaches to study functions of CAMs are presented including the use of specific antibodies, recombinant pro-
teins, and synthetic peptides. We also discuss how unravelling of the 3D structure of CAMs provides novel pharmacological tools for dis-
section of CAM-induced signalling pathways and offers therapeutic opportunities for a range of neurological disorders. 
Key Words: Recombinant, peptide, ligand, NCAM, cadherin, L1, pharmacology. 
INTRODUCTION 
  Cell adhesion molecules (CAMs) are glycoproteins found on 
the cell surface that mediate cell-cell and cell-extracellular matrix 
(ECM) adhesion. CAMs can be divided into four classes: integrins, 
cadherins, members of the immunoglobulin (Ig) superfamily, and 
selectins. The first three classes are ubiquitously expressed in the 
nervous system. CAMs are not only 'mechanical' regulators of cell 
adhesion, but also signal transducing receptors. CAM-induced in-
tracellular signalling is triggered via homophilic (CAM-CAM) and 
heterophilic (CAM - other counter-receptors) interactions resulting 
in a variety of cellular responses. These include neurite outgrowth 
and axonal pathfinding, synapse formation and remodelling, modu-
lation of cell motility and survival, to mention a few. Because of 
this diversity CAMs not only play a pivotal role in the function of 
the nervous system under normal conditions, but also are involved 
in numerous pathological processes such as inflammation, neurode-
generation, and cancer. One strategy used to address CAM function 
is to study cells with genetic knock-out or knock-in of CAMs. 
However, it is not always possible to obtain the relevant constructs 
for a particular protein, and many animal systems are not easily 
amenable to genetic modifications. Therefore, it has become impor-
tant to develop pharmacological tools that can target homophilic 
and/or heterophilic interactions of CAMs and thus modulate cellu-
lar responses induced by CAM binding. 
  This review discusses the progress in CAM pharmacology fo-
cusing on cadherins and CAMs belonging to the Ig superfamily, 
such as NCAM and L1 (see [178] for a detailed description of neu-
ral CAMs of the Ig-superfamily). We outline the structural basis of 
CAM-mediated cell adhesion and CAM-induced signalling. Differ-
ent pharmacological approaches to study the functions of CAMs are 
presented, including the use of specific antibodies, recombinant 
proteins, and synthetic peptides. We also discuss how unravelling 
of the 3D structure of CAMs provides novel pharmacological tools 
for dissection of CAMs-induced signalling pathways and offers 
therapeutic opportunities for a range of neurological disorders. 
I. STRUCTURAL BASIS OF CAM-MEDIATED CELL AD-
HESION 
Cadherins 
  Cadherins are defined by the presence of the cadherin domain 
(CD) mediating Ca
2+-dependent homophilic interaction. Calcium 
ions bind with the linker region that connects two CDs ensuring the 
rigid conformation of the cadherin molecules, which is a prerequi- 
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site of cadherin-mediated cell adhesion (Fig. (1A)). Based on the 
domain layout, cadherins are currently classified into seven sub-
families (see [167] for review). Among these, classic vertebrate 
cadherins were identified first as mediators of Ca
2+-dependent ad-
hesionincultured cells and, independently, as regulators of morpho-
genesis [162]. More recently, close attention was also drawn to 
protocadherins, which are only found in vertebrates and similarly to 
classic cadherins, can localize to synapses. These two cadherin 
subfamilies are most extensively characterized with regard to their 
structure and interaction partners (Fig. (1A), see [163] for details). 
  Classic cadherins bind to /,, and p120catenins, which in 
turn interact with the actin cytoskeleton and the Rho family of 
GTPases inducing intracellular signalling and rearrangement of the 
cytoskeleton (reviewed in [194]). In addition, p120 can bind the 
non-receptor tyrosine kinases Fer and Fyn. These kinases phos-
phorylate Tyr142 of -catenin, and this (unphosphorylated) tyrosine 
is necessary for the -catenin/-catenin association [119]. For pro-
tocadherins, only three interaction partners have been identified so 
far. First, the Pcdh/CNR protocadherins interact with Fyn indicat-
ing that they also might play an important role in signalling [80]. 
Second, one of the splice variants of protocadherin 7 interacts with 
the  isoform of protein phosphatase 1 (PP1, [195]). Third, the 
binding of protocadherin 18 to the phosphotyrosine-binding domain 
of the adaptor protein Disabled 1 (Dab1) has been reported [55]. 
  Extracellularly, cadherins participate in heterophilic interactions 
with integrins [20] and the fibroblast growth factor receptor (FGFR, 
[185]), an interaction crucial for N-cadherin-induced neurite out-
growth (see Section III for details). 
  The mechanism of the cadherin-mediated homophilic interac-
tion is still unclear (Fig. (1B)). Classic cadherins have been shown 
to form two types of dimers, namely cis (parallel association of 
molecules on the same plasma membrane) and trans (antiparallel 
association of molecules protruding from opposing cell mem-
branes). Crystal structure studies of the CD1-CD2 module of N- 
and E-cadherins have shown that the formation of the cis-dimer is 
dependent on the presence of Ca
2+, which stabilizes the CD chains 
and makes them resistant to proteolysis. Moreover, cis-dimers serve 
as blocks for further lateral clustering shown to be a prerequisite for 
stable cell adhesion [193]. The mechanism of trans-interaction of 
cadherins remains controversial (Fig. (1B)). Whereas initial studies 
only suggested an interaction between the two outmost domains of 
opposing N-cadherins, possibly with a zipper-like formation [147], 
more recent data suggest that the five CDs show variable degrees of 
lateral overlap [150]. Full lateral overlap of trans-dimers would 
imply a 20-25 nm distance between the opposing cell membranes, 
which is consistent with that found at adherens junctions. The clas-
sic cadherin-catenin complex is a principal component of the synap-
tic adherens junction. Protocadherins that localize to synapses in-254    Current Neuropharmacology, 2007, Vol. 5, No. 4 Kiryushko et al. 
clude arcadlin and the Pcdh/CNR protocadherins. However, their 
role in synaptic adhesion is not yet elucidated. 
L1-CAM 
  The L1-CAM (Fig. (1A)) belongs to the CAM subfamily also 
comprising NrCAM, neurofascin, axonin (ankyrin-binding glyco-
proteins), and the so-called close homolog of L1 (CHL1) (see [23] 
for details). L1-CAM participates in homophilic interactions and 
bindsnumerousheterophilic ligands including other CAMs (NCAM, 
TAG-1/axonin-1, contactin/F3/F11), proteoglycans (neurocan and 
phosphacan), ECM-associated molecules (laminin, tenascin), neu-
ropilin-1, and receptor tyrosine phospatases (reviewed in [152]). L1 
also binds in cis to FGFR and integrins. Interaction with FGFR (the 
membrane proximal fibronectin type III (F3) module of L1 pre-
sumably interacts with the CAM homology domain, CHD, in the  
FGFR) occurs as a result of homophilic L1 binding and results in an 
activation of the FGFR [38]. Association of L1 with integrins 
modulates cell adhesion to ECM and increases cell motility and 
migration [41]. L1 presumably interacts both with RGD-binding 
integrins (through a conserved RGD motif in the Ig6 module of L1 
[168]), and with non-RGD-binding integrins (through the third F3 
module of L1, [148]). How L1 modulates integrin-mediated adhe-
sion, however, remains unknown. 
  Intracellularly, a conserved motif in the cytoplasmic domain of 
L1 interacts with the cytoskeleton-associated proteins including 
ankyrin, which via the cytoskeletal protein spectrin couples to F-
actin. When this motif is tyrosine phosphorylated, the microtubule-
associated protein doublecortin (DC) is recruited, which in turn can 
couple with microtubules. These two interactions coupling L1 to  
Fig. (1). Structural basis of CAM-mediated cell adhesion. (A) Domain structure of classic and proto- cadherins, L1, and NCAM 180/140. Binding partners for 
cytoplasmic tails of CAMs are shown. (B) A model of cadherin-mediated cell adhesion (shown for N-cadherin). (C) Two proposed mechanisms of homophilic 
L1 binding. Note that the cartoon of L1 is shortened to highlight Ig1-Ig6. The horseshoe (I) and the extended (II) conformations of L1 exist in dynamic equi-
librium and may underlie two different mechanisms of homophilic L1 binding, occurring in the cooperative (1) or modular (2) mode. See text for details. (D) 
A model of homophilic NCAM binding. Top: crystal structure of NCAM Ig1-Ig2-Ig3 showing interaction between the three Ig-modules. Bottom: organization 
of the extracellular part of NCAM molecules engaged in both a flat and a compact zipper. The large ellipsoids correspond to the two interacting Ig1-Ig2-Ig3 
constructs as shown in the leftmost part (modified from [73]). Pharmacology of Cell Adhesion Molecules of the Nervous System  Current Neuropharmacology, 2007, Vol. 5, No. 4    255
the cytoskeleton may play a crucial role in L1 function. Further-
more, L1 binds the adaptor protein AP-2, which is involved in en-
docytosis [66]. 
  Several models for homo- and heterophilic L1 binding have 
been proposed involving from one [197] to six [52] Ig-modules of 
the molecule (reviewed in [53]). A study based on pathological 
missense mutations of human L1 suggests that the first four do-
mains of L1 adopt a horseshoe structure stabilized by Ig1-Ig4 and 
Ig2-Ig3 interactions ([4], Fig. (1C, I)). However, this predominant 
conformation may reversibly open resulting in an extended confor-
mation, in which Ig1-Ig6 assumes a linear, rod-like shape (Fig. (1C, 
II)). Correspondingly, two putative mechanisms of homophilic L1 
trans-interactions exist. In the first model, horseshoe-like structures 
of opposing L1 molecules do not open up, but rather interact with 
one another in trans. The interaction is mediated by non-covalent 
bonds between Ig3 of one protein with the horseshoe fold of the 
other L1 molecule ('cooperative mode', Fig. (1C, 1)). The second 
proposed mechanism suggests that Ig1-Ig4 first converts into its 
extended conformation, and then binds to Ig1-Ig4 of an opposing 
L1 protein ('modular mode', Fig. (1C, 2)). Interestingly, with some 
ligands, the extracellular region operates in a modular mode (bind-
ing is mediated by individual Ig domains), whereas with other 
ligands, it operates in a cooperative mode (several Ig domains form 
a horseshoe structure that is critical for binding, Fig. (1C)). The 
modular mode of interaction has been demonstrated for such 
ligands of L1 as neurocan and integrins. The cooperative mode is 
employed for L1 binding to itself, Ig CAMs, axonin-1, and contac-
tin [53]. In addition, L1 has also been shown to spontaneously 
trimerize via its third F3-module. The resulting L1 trimers have a 
higher affinity for both homophilic and heterophilic ligands and 
increase the neurite-promoting ability of L1 in PC12 cells [50]. 
NCAM 
  The neural CAM, NCAM (Fig. (1A), reviewed in [177]), be-
longs to the Ig family of CAMs. As a result of alternative splicing, 
several NCAM isoforms are generated, in particular the transmem-
brane molecules of 140 kDa and 180 kDa, which differ in the size 
of their C- (cytoplasmic) termini, and the 120-kDa isoform attached 
to the cell membrane by a GPI anchor. The three isoforms show 
stage- and cell type-related differences in expression. NCAM-180 is 
predominantly expressed by neurons late in development at post-
synaptic densities, NCAM-140 is expressed by both glial cells and 
neurons localizing to growth cones and axons, whereas expression 
of NCAM-120 is restricted to glia. Also, the three isoforms induce 
partially diverging signalling pathways (see Section II for details). 
NCAM carries an unusual carbohydrate moiety polysialic acid 
(PSA), posttranslationally attached to the Ig5 module and currently 
thought to reduce NCAM-mediated adhesion (reviewed in [75]). 
Besides, sequences encoded by the exons termed VASE, a, b, c, and 
AAG can be optionally inserted in the extracellular part of NCAM. 
Duringdevelopment, expression of PSA-NCAM decreases, whereas 
the amount of VASE-containing transcripts rises. Presumably, these 
two processes conjointly switch the function of NCAM from a plas-
ticity- to a stability-promoting molecule. The cytoplasmic tail of 
NCAM-140 and -180 can be phosphorylated at serine and threonine 
residues [5], and the phosphorylation on at least one threonine is 
involved in the NCAM-mediated activation of the transcription 
factor NFB [98]. Recently, tyrosine phosphorylation of NCAM 
also was reported and demonstrated to have an inhibitory effect on 
neurite outgrowth [30]. 
  Heterophilic partners of NCAM include ECM-associated mole-
cules (such as agrin and neurocan, reviewed in [14]), TAG-
1/axonin-1 [105], and GDNF and GFR receptor [115]. The Ig4 
module of NCAM also binds to L1 in the cis-position. This associa-
tion seems to be dependent on simultaneous NCAM-NCAM bind-
ing, and has a synergistic effect on L1-mediated cellular adhesion, a 
phenomenon, which has been termed "assisted homophilic L1-L1 
trans-binding" [64, 65, 86]. In addition, the second F3 (F3,2) mod-
ule of NCAM interacts in cis with the third immunoglobulin (D3) 
module of FGFR resulting in the induction of intracellular signal-
ling [72]. This interaction has been shown to be involved in 
NCAM-mediated neurite outgrowth and survival rendering the site 
of the NCAM-FGFR interaction an attractive target for drug design 
([72], see Section IV for details). The first F3 module of NCAM 
(F3,1) also may interact with FGFR, since antibodies specific for 
F3,1 inhibit NCAM-stimulated neurite outgrowth [3]. Moreover, 
peptides derived from NCAM-F3,1 stimulate FGFR activation and 
FGFR-dependent neurite outgrowth and cell survival (see Section 
IV for details). 
  The major cytoplasmic partners of NCAM are the signalling 
molecules phospholipase C (PLC, [38]), protein kinase C
(PKC, [94, 82]), growth-associated protein 43 (GAP-43, [104]), 
and the Src family non-receptor tyrosine kinase Fyn [7]. Binding 
with Fyn is mediated by a direct interaction between NCAM and 
RPTP [10]. In addition, NCAM interacts with cytoskeletal pro-
teins. Both NCAM-140 and NCAM-180 can associate with -and 
-tubulin [15], and NCAM-180 is the predominant isoform binding 
brain spectrin [120], which in turn interacts with multiple targets 
including filamentous actin, Ca
2+ pumps, voltage-gated Na
+ chan-
nels, and acidic phospholipids (see [94] and references therein). 
  Early models of homophilic NCAM interaction suggested either 
a binding between the Ig3 modules of opposing NCAM molecules 
or an antiparallel binding between all five Ig domains. However, a 
recent crystal structure of the Ig1-Ig2-Ig3 triple module of NCAM 
suggests a more complicated mechanism ([155], Fig. (1D)). In this 
model,theIg1 and Ig2 modules mediate cis-dimerization of NCAM, 
whereastheIg3 module mediates trans-interactions between NCAM 
molecules through simultaneous binding to the Ig1 and Ig2 modules 
(Fig. (1D), top). This arrangement results in two perpendicular zip-
pers forming a double zipper-like NCAM adhesion complex (Fig. 
(1D), bottom). 
II. SIGNALLING BY CAMS IN THE NERVOUS SYSTEM 
  All CAMs have important and varied functions in regulating 
cell behaviour and tissue organization. In addition to supporting 
stable cell-cell contacts, they also participate in numerous dynamic 
events such as neurite outgrowth, cell proliferation, synaptogenesis, 
and tumour progression (see Section III for details). Such diverse 
outcomes of CAMs interactions are not surprising, since CAMs not 
only contribute to cell adhesion, but also act as cell-signalling re-
ceptors. The CAMs described here use both 'common' and 'specific' 
signalling pathways to initiate cellular events. The 'common' signal-
ling cascade can be activated by all three CAM types and is associ-
ated with the FGFR, whereas 'specific' signalling cascades are in-
duced through the cytoplasmic tails of the respective CAM mole-
cules. 
CAM Signalling via the FGFR 
  Neurite outgrowth induced by activation of N-cadherin, L1, and 
NCAM has been shown to require the tyrosine kinase activity of 
FGFR [185]. This receptor also is involved in CAM-induced sur-
vival [151, 108] and regulation of synaptic function [95, 172]. It 
must be noted, however, that the degree of FGFR involvement in 
CAM-induced signalling varies depending on the cell type and 
developmental stage ([140], see also [71] and references therein). 
FGFR belongs to a family of high affinity receptor tyrosine kinases 
and is comprised of three Ig modules (D1-3) and a split tyrosine 
kinase domain. Four FGFR tyrosine kinases (1-4) have been identi-
fied so far, the FGFR1 being the most ubiquitous FGFR type in the 
nervous system. FGFR is thought to be required for CAM-induced 
neurite extension, since differentiation can be abolished by antibod-
ies against FGFR, by peptides competitively disrupting the FGFR 
binding to CAMs, by the expression of a dominant-negative FGFR, 
and by specific FGFR antagonists (see [70] and references therein). 256    Current Neuropharmacology, 2007, Vol. 5, No. 4 Kiryushko et al. 
The D1-D2 domains of FGFR1 (Fig. (2A)) have been shown to 
associate with N-cadherin (CD4, [188]) and with L1 (presumably 
thefourthF3module,[38]),andthe D2-D3 of FGFR binds to NCAM 
(F3 modules, [72]). Extracellular interactions between CAMs and 
FGFR induce dimerization and autophosphorylation of FGFR (Fig. 
(2A), see [73] for details). Subsequently, the cytoplasmic tail of 
FGFR serves as a docking site for several proteins. One of them is 
PLC, which becomes activated upon binding and cleaves phospha-
tidylinositolbisphosphate (PIP2) to generate inositol-trisphosphate 
(IP3) and diacylglycerol (DAG). IP3 induces Ca
2+ release from 
intracellularCa
2+stores,whereas DAG can be converted to 2-arachi-
donoylglycerol (2-AG) and arachidonic acid (AA), which both can 
induce Ca
2+ entry via plasma membrane Ca
2+ channels ([71] and 
references therein). The resulting increase in the cytoplasmic Ca
2+
concentration leads to the activation of calmodulin kinase II (CaM-
KII), and, subsequently, the cAMP response element binding pro-
tein, CREB. Moreover, Ca
2+ and/or DAG stimulate PKC, which in 
turn launches the signalling cascade Raf-Ras-MEK-MAPK also 
resulting in the activation of CREB [81]. FGFR signals are also 
transduced via the FRS2/FRS3-SHP2-GRB2 docking protein com-
plex to the SOS-Ras-MAPK and GAB1/GAB2-PI3K-PDK-Akt 
signalling cascades. Phosphatidylinositol 3-kinase (PI3K) and Akt 
are intimately involved in the CAM-mediated neuronal survival 
[99, 108, 31]; moreover the PI3K activation leads to the phosphory-
lation of Akt [156]. The targets of Akt include the transcription 
factors CREB and NFB [40, 67]; however, the genes activated by 
NFB or CREB downstream of CAM and responsible for CAM 
cellular effects remain to be identified. 
Signalling Pathways Associated with Cytoplasmic Domains of 
CAMs 
Cadherins 
  The cytoplasmic tail of classic cadherins binds to various cyto-
solic and membrane proteins (Fig. (2B), left), including catenins, 
kinases, phosphatases, heterotrimeric G proteins, adaptor proteins, 
and presenilin 1 (see [28] and references therein). It contains two 
Fig. (2). Intracellular signalling by CAMs. Signal transduction pathways associated with FGFR (A) and cytoplasmic parts of cadherins (B), L1-CAM (C), and 
NCAM (D). Stippled arrows indicate weak interactions and/or putative signalling links. See text for details. Pharmacology of Cell Adhesion Molecules of the Nervous System  Current Neuropharmacology, 2007, Vol. 5, No. 4    257
major binding regions: the C-terminal domain and the juxtamem-
brane domain (JMD, situated proximal to the plasma membrane). 
The C-terminal domain mainly binds to -catenin and the /-
catenin complex, which anchors cadherins to the actin cytoskeleton 
[79]. The JMD interacts with p120-catenin family members and 
participates in the regulation of cell-cell adhesion and cell physiol-
ogy by affecting cadherin clustering, cytoskeletal dynamics and 
calcium influx (reviewed in [1]). In addition, p120-catenin interacts 
with nonreceptor tyrosine kinase Fyn, which is involved in multiple 
intracellular signalling events (see below). 
  In addition to their role within the cadherin complex, both the 
- and p120-catenin subfamilies contribute to signalling when un-
coupled from cadherins, in particular by regulating Rho GTPase 
activity [2, 111]. Small GTPases of the Rho family (Rac1, Cdc42, 
and RhoA) are modulated upon homophilic binding of cadherins, 
and, moreover, they can reciprocally affect cadherin functions 
[194]. The effect of cadherins on each Rho GTPase varies depend-
ing on the cellular context and cross-talk between different Rho-
GTPases; however, the most well characterized responses triggered 
by cadherin ligation are the activation of Rac1 and the inhibition of 
RhoA (Fig. (2B), see [194, 184] and references therein), which 
occur, respectively, within minutes and hours of cadherin binding. 
Activation of Rac1 regulates actin polymerization by recruiting the 
actin nucleator complex Arp2/3 to cell contacts thereby stabilizing 
the cadherin complex (see [84] for details). 
  There has not been established an enzymatic link between cad-
herin ligation and the inhibition of RhoA. However, p120-catenin 
not bound to cadherin interacts with RhoA [101] and inhibits its 
activation [2]. These activities of p120-catenin are dependent on its 
interaction with the JMD [111, 118]. Thus, p120-catenin may exist 
in two distinct states in the cytoplasm: (1) cadherin-bound, not af-
fecting Rho GTPase activity, and (2) unbound, interacting with 
RhoA and preventing its activation (Fig. (2B)). The switch between 
these two states would provide a mechanism for regulation of cy-
toskeleton dynamics and Ca
2+ concentration in the vicinity of the 
junction. Interestingly, the clustering of N-cadherin observed during 
synaptic maturation in vivo is associated with the uncoupling of 
p120-catenin [134], and cytosolic pools of p120-catenin can be 
detected in the developing CNS [22]. It has been suggested that at 
immature synaptic contacts, N-cadherin is present in small clusters 
with restricted adhesive activity, which include bound p120-
catenin. In this case, Rac1-associated signalling is activated con-
tributing to the organizing of the actin cytoskeleton and to the as-
sembly of the synaptic junction. During synaptic maturation, N-
cadherin clusters into larger strongly adhesive puncta as a result of 
cadherin homophilic binding and/or synaptic activity. As a result, 
p120-catenin uncouples from the N-cadherin complex and inacti-
vates RhoA leading to disassembly of contractile actin-myosin 
filaments. This process contributes to the stabilization of the synap-
tic complex and to the increase in synaptic efficacy. In addition, 
inhibition of RhoA may induce Ca
2+ entry into the cytoplasm by 
activating voltage-gated Ca
2+ channels of the plasma membrane 
further increasing synaptic function [118]. 
  The signalling pathways associated with the cytoplasmic do-
mains of protocadherins remain elusive (Fig. (2B), right). Protocad-
herin 18 supposedly tyrosine phosphorylates the docking protein 
Dab1 upon binding. One important consequence of Dab1 tyrosine 
phosphorylation might be the nucleation of the multi-protein signal-
ling complex Fes which modulates cytoskeletal dynamics (see 
[158] for review). Phosphorylated serine/threonine phosphatase 
type 1 (PP1) activated by the protocadherin 7 might modulate 
the activity of caspase-9 involved in neuronal apoptosis [29] and 
IP3-induced Ca
2+ release from intracellular stores [165]; however, 
no direct relationship between protocadherin ligation and these 
events has so far been demonstrated. The most well-established 
signalling pathway associated with the cytoplasmic tail of proto-
cadherins involves the tyrosine kinase Fyn, which serves as a dock-
ing protein for the focal adhesion kinase, FAK. FAK interacts with 
numerous proteins and may activate the MAPK pathway via several 
routes [139]. In particular, recruitment of FAK leads to a sequential 
activation of the small GTP-binding protein c-Ras1 and the ser-
ine/threonine kinases c-Raf-1 and MAPK1/2. The phosphorylation 
of MAPK1/2 eventuates in the activation of the transcription factors 
CREB and Fos [27]. Interestingly, Fyn is also associated with the 
cadherin complex via p120-catenin and phosphorylates -catenin 
on Tyr142, the residue essential for the -catenin--catenin interac-
tion [119]. Thus, Fyn may reciprocally modulate the cadherin com-
plex. In addition, Src family kinases including Fyn can positively 
regulate non-selective cation channels of the plasma membrane [54, 
175] and L-type voltage-gated Ca
2+ channels ([59], and references 
therein), thus increasing Ca
2+ entry into the cytoplasm. 
L1-CAM 
  Like cadherins, L1 and NCAM also activate the MAPK signal-
ling pathway. In L1-induced signalling, activation of the nonrecep-
tor tyrosine kinase p60c-src (Src) is required for MAPK phosphory-
lation (Fig. (2C), [141]). Cross-linking of L1 molecules on the 
growth cone membrane can induce internalization of L1 via Src. 
This internalization is mediated by the small GTPase dynamin and 
leads to a sequential activation of PI3K, Rac, and MAPK (Fig. 
(2C), [141]). The L1-mediated MAPK activation also induces the 
expression of several genes associated with motility and invasion 
[149]. MAPK2 in turn can phosphorylate L1 at serines; thus, L1 
signalling may reciprocally regulate L1 function ([138], Fig. (2C)). 
  Integrins as binding partners of L1 can also contribute to the 
L1-induced signalling. In particular, 1 integrins also signal via
Src, PI3K, and Rac1 to activate MAPK [126] raising the possibility 
that L1 and integrins may cooperate on some intracellular signalling 
'routes' and/or signal via each other. 
NCAM 
  For NCAM, phosphorylation of MAPK1/2 was demonstrated in 
primary neurons following NCAM clustering on the cell surface, 
homophilic  trans-binding, and treatment with synthetic peptide 
ligands (see [70] for references). Clustering of NCAM-140, but not 
NCAM-180, resulted in MAPK phosphorylation, and this event was 
mediated by activation of the Fyn-associated signalling cascade 
(Fig. (2D), [140]). Interestingly, Fyn was recently co-precipitated 
also with NCAM-180 [10] and shown to interact with both NCAM-
140 and -180 via receptor protein tyrosine phosphatase  (RPTP). 
The affinity of the RPTP-NCAM-180 interaction was lower than 
that of the RPTP-NCAM-140 interaction, but these observations 
suggest that an NCAM-180-Fyn interaction might also occur. 
  Association between NCAM and Fyn has been shown to be 
'reinforced' by the cytoskeletal protein spectrin, which predomi-
nantly binds to NCAM-180, but also to NCAM-140 [160], and 
serves as a scaffold for the NCAM-RPTP-Fyn complex. Another 
important function of spectrin may be recruitment of the growth-
associated protein GAP-43. GAP-43 presumably coexists in com-
plexes with NCAM at the plasma membrane and is known to be 
indispensable for the NCAM-induced neurite outgrowth (Fig. (2D), 
see [83] and references therein). Moreover, recent experimental 
evidence suggests that expression of GAP-43 might act as a 'switch' 
between NCAM-140- and NCAM-180-induced signalling [83]. In 
the presence of GAP-43, NCAM-induced neurite outgrowth re-
quires functional association of NCAM-180/spectrin/GAP-43, 
whereas in the absence of GAP-43, the NCAM-140/Fyn-associated 
signalling pathway seems pivotal [83]. 
  To participate in signalling impinging on neurite outgrowth, 
GAP-43 has to be phosphorylated and thereby activated by protein 
kinase C (PKC, [83] and references therein). PKC is activated as a 
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utes to the activation of the Fyn-cascade joining it at the level of 
Raf (Fig. (2D), [81]). NCAM might also activate heterotrimeric G-
proteins [36] resulting in stimulation of adenylyl cyclase and pro-
duction cAMP. This leads to the activation of PKA and its effectors 
CREB and another transcription factor, c-fos (Fig. (2D), [62]). Fi-
nally, NCAM can via nitric oxide synthase (NOS) induce produc-
tion of cyclic guanosine monophosphate (cGMP), which in turn 
activates protein kinase G. This signalling pathway is involved in 
NCAM-induced neurite outgrowth and survival in primary neurons 
[32]. 
III. PHARMACOLOGICAL TOOLS TO STUDY CAM 
FUNCTION 
  The first pharmacological tools developed to study CAM func-
tions were antibodies targeting specific CAM epitopes followed by 
CAM-derived recombinant proteins. In this section, we describe the 
advantages of these approaches in vitro and in vivo as well as their 
drawbacks, which have been partially compensated for by introduc-
tion of structure-based design of CAM ligands (discussed in Section 
IV). The major pharmacological approaches used for studying 
CAMs are summarized in Table 1.
Cadherins 
  Cadherins have important and varied functions in the regulation 
of cell behaviour and tissue organization. Besides supporting stable 
cell-cell contacts, they also participate in dynamic events. In the 
nervous system, these include cell sorting and tissue segregation 
[49], cell locomotion during gastrulation [13], neurite growth and 
guidance [103, 127], synaptogenesis and modulation of synaptic 
function ([11, 60, 164], reviewed in [163]). Traditionally, cadherin 
Table 1.  Pharmacological Tools to Study CAM Function 
Pharmacological Approach  Selected Studies 
Cadherins:
'Ca
2+-switch' method [112,21] 
Recombinant cadherin fragments [13,91,85] 
Monitoring the 2D movement of cadherin-coated beads [90,157] 
Synthetic peptides 
Role of cadherins in axonal growth and targeting [121,48] 
Role of cadherins in formation of cell junctions and postsynaptic density [181,56] 
Cadherin-induced modulation of LTP [191] 
Identification of an N-cadherin motif interacting with FGFR [185, 188] 
Cadherin-mediated adhesion [13] and lateral clustering [193] 
Cadherin-induced neurite outgrowth [173] 
Recruitment of catenins and regulation of cytoskeleton by cadherins [85.91] 
Time-course of cadherin-induced modulation of Rac and Rho [112,21] 
Functional link between the cytoplasmic domain of N-cadherin and voltage-gated Ca
2+ channels [118] 
Anchoring of cadherins to the cytoskeleton [137,91,170] 




Recombinant L1 proteins 
Chromophore-assisted laser inactivation of L1 [180] 
Synthetic peptides 
Role of L1 in cell migration [97] and aggregation [125,68] 
Interactions L1:axonin-1 [87] and L1:NCAM [57] 
Role of L1 in neurite outgrowth/fasciculation [42,43] and Schwann cell differentiation [145] 
Triggering of intracellular signalling by L1 [78,141,39] 
Involvement of phosphatases and MAP kinases in L1-induced signalling [78,141,166] 
Mimicking of neurite- and survival-promoting effects of L1 in vitro [39] 
Role of FGFR in the L1-induced neurite outgrowth [37] 
Signalling pathways involved in the L1-induced neuroprotection [99] 
Role of individual modules of L1 in the L1:integrin binding [113,148] and in the L1:neuropilin-1 bind-
ing [19] 
Mapping the homophilic binding domain in L1 [197,52] 
L1-induced acceleration of nerve regeneration in vivo [133,190] 
The role of L1 in growth cone protrusion and neurite extension [161] 
Identification of peptide inhibitors [57,198] of L1 function 
NCAM:
NCAM-specific antibodies 
Recombinant NCAM proteins 
Chromophore-assisted laser inactivation of NCAM [180] 
Enzymatic removal of NCAM-associated PSA 
Synthetic peptides 
NCAM-mediated cell adhesion [12,135] 
Role of NCAM in neurite growth, guidance and fasciculation [136,93] 
Isolation of PSA-binding regions of NCAM [24] 
Mapping of functionally important sites of NCAM [47] 
Role of NCAM in neuronal migration [143] and long-term potentiation [100, 128] 
Role of GAP-43 in the NCAM-induced neurite outgrowth [104] 
Elucidation of the mechanism of homophilic NCAM binding [25,155] 
Role of individual modules of NCAM in different cell functions [46,123] 
The role of NCAM in growth cone protrusion and neurite extension [161] 
Role of PSA-NCAM in axonal growth and branching [34,196], cell migration [74,6], and synaptic 
plasticity [107,33] 
Identification of PSA-derived peptides promoting neuronal differentiation and migration [171], and 
improving long-term memory [44] 
Identification of peptides mimicking NCAM function [129,76,154,116,132,72,3,8] and possessing 
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function has been studied by monitoring the behaviour of cultured 
cells as they grow to confluence and form adhesive contacts [13, 
92]. However, this method has significant limitations because (1) 
homophilic cadherin ligation is difficult to evaluate, and (2) the 
time-course of adhesion formation does not allow to study cadherin 
effects on rapidly changing cellular parameters (e.g., the levels of 
enzyme activities or the intracellular Ca
2+ concentration). Another 
common approach, the 'Ca
2+ switch method', exploits the Ca
2+ de-
pendency of homophilic cadherin adhesion. In this approach, the 
formation of cadherin-mediated junctions is manipulated by varying 
the level of extracellular Ca
2+. At low extracellular Ca
2+, cadherin 
function is blocked; restoration of the Ca
2+ level results in the ref-
ormation of cell junctions and induction of cadherin-mediated in-
tracellular signalling [112, 21]. These two methods have success-
fully been used to 'switch on' the cadherin-mediated signalling, 
whereas 'switching off' mostly was accomplished by using inhibi-
tory antibodies to cadherins. In combination, these approaches were 
used to study the regulation of the function of C-cadherins during 
activin-induced morphogenesis [13], the modulation of Rho 
GTPases and -catenin by cadherin ligation [21], the role of N-
cadherin in the growth and targeting of thalamocortical axons [121] 
and in the formation of Schwann cell junctions [181], the role of 
Src kinases in the stabilization of cadherin-mediated adhesion 
[114], the involvement of R- and B- cadherins in the axonal guid-
ance of the optic nerve [48], the role of cadherins in the subcellular 
organization of the postsynaptic density [56], the modulation of 
long-term potentiation by a protocadherin Arcadlin [191], and for 
the identification of an N-cadherin motif interacting with FGFR 
[185, 188]. 
  However, the major drawback of the above approaches is that 
they are not able to distinguish between the direct cadherin signals 
(those activated as direct consequences of cadherin ligation) and the 
juxtacrine signals (those requiring cadherin adhesion to bring cell 
surfaces together, but not being direct consequences of cadherin 
ligation). This distinction is fundamental for any rigorous analysis 
of cadherin function. 
  An important advance was the development of recombinant 
cadherin-specific ligands. Several proteins have been produced 
encompassing the complete ectodomains of C-cadherin [13], N-
cadherin [173, 91], or E-cadherin [85, 110]. When presented on 
planar substrata or coated on beads, these ligands supported cad-
herin-specific adhesion [13], lateral clustering [193], and neurite 
outgrowth [173] recruiting catenins and regulating the cytoskeleton 
[85, 91]. These proteins have proved to be powerful tools to sepa-
rate the cadherin-activated from cadherin-dependent cell signals, in 
particular to evaluate the time-course of cadherin-induced modula-
tion of Rac and Rho [112, 21]. They have also helped establishing a 
novel method for studying the dynamics of functional anchoring of 
cadherins to the actin cytoskeleton. In this method, a biophysical 
approach was used enabling the authors to monitor the two-
dimensional movement of single or small clusters of proteins [90]. 
Ligand-coated particles were forced to contact different domains of 
the plasma membrane using optical tweezers. Thereafter, the move-
ment of the particles bound to membrane receptors could be moni-
tored with nanometer precision by video microscopy and single-
particle tracking [157]. Using cadherin-coated beads as ligands, it 
was thus possible to follow the anchoring of E-cadherins [137] or 
N-cadherins [91, 170] to the cytoskeleton, and to perform dose-
response analysis and pharmacological perturbations to study the 
molecular mechanisms controlling the anchoring. 
  Also, a recombinant ligand corresponding to the intracellular 
regions of cadherins was generated. The juxtamembrane domain 
(JMD) of cytoplasmic tail of N-cadherin was produced and used to 
study the functional link between the N-cadherin JMD and voltage-
gated Ca
2+ channels. It was found that the infusion of the soluble 
JMD into ciliary neurons decreased the amplitude of the high-
threshold voltage-activated Ca
2+ current, and this effect was medi-
ated by RhoA [118]. 
L1-CAM 
  The L1-CAM plays a pivotal role in the function of the nervous 
system (reviewed in [58]; see also [39] and references therein). 
During development, it participates in regulation of neuronal migra-
tion and survival, neurite outgrowth, axonal pathfinding, and synap-
togenesis. In the adult, L1 is involved in synaptic plasticity, includ-
ing spatial learning and memory and induction and maintenance of 
LTP in the hippocampus. Mutations of L1 in mice and humans have 
been demonstrated in X-linked chromosomal diseases, such as the 
MASA syndrome (mental retardation, aphasia, shuffling gait), spas-
tic paraplegia type 1, and agenesis of the corpus callosum [26, 69]. 
This multiplicity of L1 functions can be explained by its ability to 
bind numerous cell surface and ECM molecules through different 
segments of its ectodomain. However, early studies on L1 function 
did not attempt to segregate activities associated with individual L1 
modules. Purified L1 and/or antibodies were mostly utilized to 
investigate the cellular effects of L1 and their molecular mecha-
nisms. First, inhibitory Fab antibodies to L1 were produced, which 
modified the migration of external granular cells from mouse cere-
bellum [97]. These Fab fragments have also been shown to decrease 
the calcium-independent aggregation of mouse cerebellar cells and 
neuroblastoma N2A cells [125]. Other monoclonal antibodies to L1 
have been demonstrated to suppress the binding between L1 and 
axonin-1 [87]. To assess the binding in this study, purified L1 and 
axonin-1 were covalently coupled to the fluorescent microspheres, 
and their aggregation was analyzed by flow cytometry. Inhibitory 
antibodies were also used to investigate the cell type specificity of 
L1-mediated cell adhesion [68], the role of L1 in neurite out-
growth/fasciculation [43], in TAG-1 induced neurite extension [42], 
and in Schwann cell differentiation [145]. Moreover, inhibitory 
antibodies to specific regions of L1 have been generated. In particu-
lar, monoclonal antibodies to an oligomannosidic carbohydrate of 
L1 have been shown to inhibit complex formation between L1 and 
NCAM [57], suggesting that the carbohydrate moiety mediates the 
L1-NCAM binding. More recently, activating antibodies were pro-
duced capable of triggering L1-mediated signalling, most probably 
by clustering L1 molecules on the cell surface [78, 141, 39]. These 
antibodies have been used to elucidate the effect of L1 stimulation 
on the activity of phosphatases in the growth cone-enriched mem-
branes [78], to study the involvement of the MAP kinase pathway 
in L1-induced signalling [141], and to demonstrate that ethanol 
disrupts the signalling link between L1 clustering and MAPK acti-
vation [166]. The antibodies enhanced neurite outgrowth from sev-
eral populations of neurons and promoted neuronal survival in vitro
[39], thus mimicking some beneficial functions of homophilic L1 
binding in vitro and suggesting that they may serve to trigger these 
functions in vivo.
  The toolkit for studying L1 signalling has been vastly extended 
by the advent of recombinant L1 proteins. Doherty et al. [37] have 
demonstrated that a soluble recombinant L1-Fc chimera stimulates 
neurite outgrowth from primary neurons in a manner similar to that 
of native L1, and that neuronal FGFR is required for this response. 
L1-Fc and L1 purified from mouse brain have been used to investi-
gate the signalling pathways involved in L1-triggered neuroprotec-
tion [99]. Furthermore, from recent studies using an array of re-
combinant L1-derived proteins, a theory has emerged suggesting 
that L1 can interact with its ligands in both a modular and a coop-
erative modes (see Section I for details). The 'modular model' was 
supported by studies showing that some binding activities of L1 
were restricted to individual domains. In particular, it was found 
that the Ig1 module supports L1 interaction with the cell surface 
proteoglycans neurocan, whereas RGD sites in the Ig6 domain are 
indispensable for L1- integrin binding [113]. More recently, another 
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using a range of recombinant L1-proteins [148]. To investigate the 
function of F3 domains of L1, the authors produced a series of con-
structs including two or three adjacent F3 modules (F3,1-2; F3,2-3; 
F3,1-3), the Ig6 module alone, or Ig6 in conjunction with adjacent 
F3 modules (Ig6-F3,1-2 and Ig6-F3,1-3), as well as the whole L1 
ectodomain. Using adhesion and immunoprecipitation assays, it 
was shown that the third F3 module of L1 spontaneously forms 
homotrimers and higher order complexes, and these complexes 
support direct RGD-independent interactions with severalintegrins. 
  A modular mode of interaction has also been demonstrated for 
L1 binding with neuropilin-1 (NP-1). L1 is known to associate with 
NP-1 and is required as part of the NP-1/Semaphorin 3A (Sema 3A) 
receptor complex for axon guidance responses [18]. Using L1 con-
structs containing missense pathological mutations, Castellani and 
coworkers [19] have shown that these responses are initiated by a 
specific trans binding of L1 to NP-1, and have confined the L1-NP-
1-binding site to the Ig1 module of L1. A peptide derived from this 
region could reverse the axonal guidance effects of Sema3A, and a 
missense mutation located in this sequence specifically disrupted 
both L1-NP-1 complex formation and Sema3A signalling. Finally, 
Zhao and Siu [197] have mapped the homophilic binding domain in 
L1. Several recombinant proteins (Ig1, Ig1-2, Ig1-2-3, Ig4-5-6, and 
fibronectin modules) were prepared and coupled to covaspheres, 
and their homophilic binding activity was determined using a co-
vasphere-to-substratum binding assay. Only the Ig2, Ig1-2, and Ig1-
2-3 constructs were capable of homophilic binding and of inducing 
neurite extension, and the Ig2-Ig2 interaction was inhibited by anti-
Ig1-2-3 antibodies and soluble Ig2. Based on these results, the 
authors proposed that Ig2 was necessary and sufficient for L1 ho-
mophilic trans-interaction. 
  However, subsequent studies of the mechanism of homophilic 
L1 adhesion have expanded this view. In particular, EM visualiza-
tion and sedimentation analysis of the Ig1-Ig6 domains of L1 re-
vealed that the protein exists in two conformations: an extended 
molecule and a globular structure with a linear tail, where Ig1-Ig4 
engaged in a horseshoe fold, and the tail represented Ig5-Ig6 [142]. 
These data suggest that with some ligands L1 operates in a coopera-
tive mode, where the horseshoe structure formed by the Ig1-Ig4 
domains is critical for the L1-ligand interaction. This hypothesis 
has been corroborated by the studies of De Angelis et al. [4], where 
a number of L1-Fc fusion proteins were generated with missense 
mutations that are associated with disease. It was found that muta-
tions located throughout Ig1-Ig6 and F3,2 interfered with both 
homo- and heterophilic interactions. More recently, the recombi-
nant L1-Fc proteins expressed in eukaryotic cells were used to iden-
tify a minimal segment in the L1 ectodomain mediating homophilic 
interaction [52]. The results indicate that Ig1-4 of L1 are critical for 
homophilic binding and neurite outgrowth; however, a larger por-
tion of the protein, comprising Ig1-Ig6, is required for optimal pro-
motion of cell adhesion and neurite outgrowth. 
  Interestingly, the pharmacological use of L1-derived recombi-
nant proteins in vivo has also been attempted. A soluble L1-Fc con-
struct promoted locomotor recovery in rats after spinal cord injury 
[133]. Also, L1-Fc accelerated rat optic nerve regeneration when 
presented on the surface of the nerve [190]. However, therapeutic 
application of recombinant L1-proteins might be limited because of 
difficulty in obtaining these reagents under highly reproducible 
conditions and/or in large amounts. 
NCAM 
  NCAM is involved in numerous physiological and pathological 
processes (reviewed in [177]). These include cell proliferation [106] 
and motility [122], neuronal differentiation [109] and survival [31], 
axon guidance [179], synaptic plasticity [192], and learning and 
memory formation [100]. Some of the NCAM effects are regulated 
by the expression of PSA (see [177]). Genetic deletion of NCAM 
does not result in severe brain dysfunction. However, NCAM-
deficient mice have a decreased brain weight and demonstrate sig-
nificant alterations in the olfactory system and hippocampus. They 
also exhibit defects in spatial learning and an anxiety-like behav-
iour. Re-expression of NCAM-180 in these mice can compensate 
for some of the behavioural alterations caused by the NCAM 
knockout [159]. Interestingly, simultaneous deletion of the genes 
responsible for NCAM polysialylation results in a severe phenotype 
including postnatal growth retardation and early death [183] indi-
cating an important role for PSA in controlling NCAM interactions 
during development. 
  As well as for cadherins and L1, initial studies on the NCAM 
function were carried out mostly using NCAM-specific antibodies. 
NCAM was first described by Jorgensen and Bock [63] as a brain 
specific antigen termed D2; however, the functional role of D2 as a 
cell adhesion molecule had not been ascertained. Thiery et al. [169] 
have independently identified NCAM as one of the molecules re-
sponsible for the in vitro adhesion of chick retinal cells and pre-
pared anti-NCAM antibodies capable of inhibiting cell adhesion. 
These antibodies have been used to demonstrate the existence   
of Ca
2+-dependent (cadherins) versus Ca
2+-independent (L1- and 
NCAM-mediated) adhesion systems [12]. Data on aggregation of 
NCAM-containing lipid vesicles and on NCAM binding to cells 
coated with anti-NCAM Fab fragments strongly suggested that 
NCAM molecules on different cells may interact directly to mediate 
cell adhesion [135]. Further studies using antibodies to NCAM 
have shown that its function is required for neurite growth, guid-
ance and fasciculation (reviewed in [136]), and interactions be-
tween spinal cord neurons and muscle cells ([24] and references 
therein). 
  At the same time, the existence of structurally and functionally 
different regions in the NCAM ectodomain was established [24]. 
To isolate NCAM regions containing a homophilic binding site or 
PSA moieties, the authors have used temperature- and enzyme-
induced generation of NCAM fragments as well as NCAM antibod-
ies ([24] and references therein). Watanabe et al. [182] performed a 
systematic study mapping structural and functional determinants of 
NCAM. Twelve different monoclonal antibodies were produced, 
each recognizing a distinct NCAM epitope. Some of the antibodies 
were inhibitory, whereas others enhanced the NCAM-mediated cell 
adhesion. The authors also generated a set of peptide fragments 
from NCAM and used their size and reactivity to construct an epi-
tope map of NCAM [47]. As a result, the location of functionally 
important sites of the NCAM molecule has been refined. 
  More recently, NCAM antibodies have been employed to study 
the signaling pathways initiated by NCAM-140 [140] and the role 
of GAP-43 in NCAM-induced neurite outgrowth [104]. Also, anti-
bodies to NCAM have been widely used to study the physiological 
role of the molecule in vivo. It has been found that NCAM is in-
volved in the migration of luteinizing hormone-releasing neurons 
into the mouse brain [143], in the initial nerve ingrowth and ramifi-
cation in the chick muscle [93], in the limb regeneration in newts 
[102], and in the long-term potentiation in rats [100, 128]. 
  The advance in the studies of NCAM function has been vastly 
accelerated by demonstrating that its ectodomain includes five con-
tiguous segments belonging to the immunoglobulin superfamily 
[25]. These authors also were first to suggest that interactions be-
tween Ig modules could be the basis for NCAM homophilic bind-
ing, and using NCAM fragments they identified Ig1, Ig2, and Ig3 as 
important for this binding. More recently, Rao et al. [124] com-
bined three approaches to identify NCAM regions involved in ho-
mophilic interactions: (1) analysis of domain deletion mutations, (2) 
mapping of epitopes of monoclonal antibodies, and (3) use of syn-
thetic peptides to inhibit NCAM function. An attempt has also been 
made to evaluate a role of individual modules of NCAM in differ-
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the first and second F3 modules, and investigated their effects on 
cell adhesion, neurite outgrowth, fasciculation of neurites, and ori-
entation of inhibitory interneurons in the cerebellar cortex. Interest-
ingly, no role for Ig3 in cell adhesion was found in this study. Nev-
ertheless, the ability of recombinant Ig3 to self-aggregate has sub-
sequently been shown [123] confirming that this domain might play 
an important role in NCAM-mediated cell adhesion. 
  An interesting strategy to study the role of L1 and NCAM in 
neurite outgrowth has been used by Takei et al. [161], who have 
employed a microscale chromophore-assisted laser inactivation 
(micro-CALI) assay to perturb the function of these proteins at 
precise times in single growth cones of embryonic dorsal root gan-
glion neurons. CALI induces loss of function of specific proteins in 
living cells by using antibodies to these proteins conjugated with 
dye malachite green. The dye absorbs 620 nm laser light and gener-
ates short-lived hydroxyl radicals that inactivate proteins within a 
small radius around the irradiation site (reviewed in [180]). Since 
inactivation only occurs when irradiation is initiated, it is possible 
to determine the time-course of cellular effects induced by such a 
'local knockout' of a given protein. Using this method, the authors 
found that inactivation of NCAM had drastically different effects 
on growth cone protrusion and neurite extension as compared to L1 
suggesting distinct roles of these proteins in different stages of neu-
rite outgrowth. 
  An important target in NCAM pharmacology is the specific 
carbohydrate, polysialic acid (PSA), posttranslationally attached to 
the Ig5 module of NCAM. NCAM is the predominant carrier of 
PSA, and expression of PSA-NCAM is associated with develop-
mental and learning-related neural plasticity (see Section I for de-
tails). Therefore, modulation of PSA levels may be a promising 
pharmacotherapy for treating a wide range of neurological disor-
ders. 
  The main analytical approach to study the role of PSA-NCAM 
has thus far been the use of an enzyme endoneuraminidase (Endo-
N) to remove PSA moiety from NCAM. PSA contains up to 200 
residues of sialic acid linearly linked by an unusual 2,8-bond, and 
Endo-N is specific for 2,8-linked sialic acid polymers with a 
minimum chain length of five [176]. Therefore, the enzyme does 
not degrade any other known sialic acid-containing structures and is 
thus a convenient tool to study the function of PSA-NCAM. The 
enzymatic approach has been used in a number of studies to dem-
onstrate the role of PSA-NCAM in axonal growth and branching 
[34, 196], cell migration [74, 6], and synaptic plasticity [107, 33]. 
However, this strategy only allows one to address the effect of ab-
rogation of PSA function. Recently, Vaithianathan et al. [174] have 
used a bacterially derived PSA, colominic acid, to mimic PSA ef-
fects in primary neurons. This technique allowed the authors to 
study the direct modulation of neuronal receptors by PSA. 
  Other promising candidates for manipulating PSA-NCAM are 
synthetic peptides that can mimic PSA functions. Recently, using a 
monoclonal antibody specific for PSA, a phage-display library was 
screened leading to the identification of two cyclic nonapeptides 
that are PSA epitope analogues. In vitro, the peptides promote axon 
growth, defasciculation and migration of neural progenitors [171]. 
In vivo, the peptides enhance migration of grafted neuroblasts in 
mouse brain and modify the trajectory of retinal ganglion cell axons 
in developing chicken retina [171]. The PSA mimetic peptide pr2 
improves spatial long-term performance in mice following post-
training intra-hippocampal injection [44]. Thus, peptides capable of 
enhancing biological activity of PSA are not only good tools for 
'switching on' PSA function, but may also have a therapeutic poten-
tial. 
IV. STRUCTURE-BASED DESIGN OF CAM MIMETICS 
  Significant progress in the design of CAM-specific ligands was 
achieved due to the solution of the 3D structure of various CAMs 
and their fragments. Sites involved in homophilic and/or hetero-
philic CAM interactions were identified and, when presented as 
peptides, often proved to have significant effects on CAM function. 
Cadherins 
  Several cadherin-specific ligands were designed based on the 
3D crystal structure of CD1 modules of N-cadherin (see [146] for 
review). It was demonstrated that CD1 of N-cadherin forms two 
dimeric structures with well-defined interactions mediating the 
formation of cis  and trans dimers [147]. Interestingly, the HAV 
motif at position 79–81, which was previously identified in peptide 
competition studies as being important for cadherin function [9, 35] 
was implicated in both structures. In accordance with this, Williams 
and coworkers [186] demonstrated that the short cyclic HAV pep-
tides inhibited N-cadherinfunction, and that the nature of the amino 
acids that flanked the HAV motif determined the specificity of the
peptides. For example, when the HAV motif was flanked by a sin-
gle aspartic acid, which mimics the natural HAVD sequence of N-
cadherin, the peptide became a selective inhibitor of N-cadherin
function. In contrast, when the HAV motif was flanked by a single
serine, which mimics the natural HAVS sequence of E-cadherin, it 
lost its ability to inhibit the N-cadherin response. Thus, subtle 
changes in the amino acids flanking the HAV motif could account 
for cadherin specificity. More recently, the same authors have de-
termined amino acid residues in CD1 of N-cadherin (INP) interact-
ing with unique sequences that flank the HAV motif in N-cadherin, 
and designed a linear peptide mimetic (INPISGQ), which func-
tioned as a highly specific and potent antagonist of N-cadherin 
function (IC50~15 M, [187]). Peptide mimetics of the correspond-
ing motif in E- or P-cadherin failed to inhibit N-cadherin function. 
A short cyclic peptide that contained only the INP motif from N-
cadherin was also a potent N-cadherin antagonist. 
  Monomeric versions of the HAVDI and INPISGQ peptides 
have been used in many studies as specific N-cadherin blockers. 
However, when cyclic peptides were generated containing a tandem 
repeat of the individual motifs, they functioned as N-cadherin ago-
nists [189]. Interestingly, the linear dimeric versions of the motifs 
also stimulated neurite outgrowth, which was inhibited by mono-
meric versions of the same motif, as well as by recombinant CD1 
module of N-cadherin and by blocking of FGFR-associated signal-
ling. These data suggest that the peptides function by binding to and 
clustering N-cadherin in neurons and thereby activating an N-
cadherin/FGFR signalling cascade. Moreover, the agonists also 
promoted the survival of several populations of CNS neurons in an 
FGFR-dependent manner [151]. Thus, the cadherin-derived pep-
tides not only represent promising tools for the study of the cad-
herin-mediated signalling, but may also be used for developing 
therapeutic agents that promote cell survival and axonal regenera-
tion. 
L1-CAM 
  The ligands derived from the 'active' sites of the L1-interacting 
molecules and L1 itself may as well be good candidates for analyti-
cal and therapeutic use. However, the structure of the L1 ectodo-
main at the atomic resolution has not yet been solved. Recently, 
crystallization and preliminary X-ray analysis of the extracellular 
Ig1-4 and F3,1-3 of L1 were attempted. Although the crystals of the 
F3,1-3 module of L1 diffracted to a resolution of 2.8Å, it was not 
possible to solve the structure [88]. The absence of structural details 
of folding and interactions between L1 modules is a major impedi-
ment in designing small molecules binding L1 and mimicking its 
functions. Horstkorte et al. [57] generated a peptide representing a 
sequence in the Ig4 domain of NCAM, responsible for the NCAM-
L1 interaction. This peptide interfered with the NCAM-L1 binding 
and inhibited neurite outgrowth in vitro. Another L1-derived pep-
tide, L1-A, spanning the H178 and G191 residues, has been shown 
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HIKQDERVTMGQNG of Ig2 may constitute a part of the L1 ho-
mophilic binding site [198]. Williams et al. [185] identified a CAM 
homology domain in the FGF receptor family and showed that syn-
thetic peptides derived from this domain specifically inhibit neurite 
outgrowth stimulated by L1, N-CAM, and N-cadherin. Conversely, 
apeptideregioninthethirdF3module of L1, SVILSGLRPYSSYHL, 
derived based on its homology to the CAM-homology domain 
(CHD) of the FGFR, inhibited the L1-induced cellular responses 
and was thus suggested to represent the FGFR binding site in L1 
(see [38] and references therein). 
NCAM 
  For NCAM as well as for L1, the simplistic modular model of 
homophilic binding has been replaced by a more complex coopera-
tive model. The X-ray structure of the Ig1-Ig2-Ig3 dimer (Fig. (2D), 
[154]) demonstrated that the cellular functions of NCAM can not 
unequivocally be assigned to individual modules, because multiple 
cis and trans interdomain interactions are involved in homophilic 
binding. It has also become clear that small molecules (e.g. pep-
tides) able to specifically affect these interactions might be both 
useful tools for dissecting NCAM-mediated signalling and promis-
ing candidates for drug design. 
  In our research group we have used two strategies to develop 
pharmacological compounds affecting NCAM function: (1) screen-
ing of combinatorial peptide libraries with fragments of NCAM, 
and (2) structural determination of binding sites in NCAM by nu-
clear magnetic resonance (NMR) and X-ray crystallography. As a 
result, a number of small molecular weight agonists and antagonists 
of NCAM have been developed mimicking or specifically inhibit-
ing NCAM-mediated cellular effects (see [8] for review). Here, we 
will focus on three of them, the C3, P2, and FGL peptides, since 
these NCAM mimetics have been extensively characterized in vitro
and shown to exert prominent effects in vivo.
  The C3 peptide, ASKKPKRNIKA, was identified by screening 
a combinatorial peptide library with biotinylated recombinant 
NCAM Ig1 [129]. To increase the potency of the peptide, C3 was 
subsequently synthesized as a dendrimer comprising four mono-
mers coupled to a lysine backbone (C3d). C3d was demonstrated to 
interact with NCAM Ig1 at a site different from that involved in the 
binding of Ig1 to Ig2 [129]. However, the cellular effects/signalling 
pathways activated by C3d have been shown to be identical to those 
activated by homophilic NCAM binding. In particular, C3d induces 
neurite outgrowth from primary neurons by increasing intracellular 
Ca
2+ and activating of FGFR, the MAP-kinase pathway and CREB 
[130, 131, 62, 154]. The peptide also promotes neuronal survival 
through phosphorylation of Akt and PKB [31] and interferes with 
NCAM-mediated cell adhesion presumably by competing with 
homophilic,  physiological NCAM binding [129]. Recently, C3d 
was demonstrated to inhibit apoptosis induced by interleukin-1
(IL1-) in beta cells by inhibiting the IL-1-induced MAPK activ-
ity [117]. 
 In  vivo, the C3d exerts a neuroprotective effect against terato-
gen-induced developmental defects when administered at embry-
onic day 14 in rats [76]. However, in adult animals, C3d impairs 
short- and long-term memory [45, 51, 16] suggesting that in the 
mature brain, the peptide might disrupt already established neuronal 
connections. Thus, the C3d peptide appears to differentially affect 
the developing and the adult nervous system. 
  The P2 peptide, GRILARGEINFK, is a conserved sequence 
fragment derived from the Ig2 module of NCAM. Based on NMR 
and crystallography studies, this peptide has been identified as a 
contact area in Ig2 interacting with Ig1 [61, 154]. The dendrimeric 
form of P2 (P2d) binds to recombinant NCAM Ig1 and triggers 
signal transduction pathways similar to those activated by NCAM. 
The peptide disrupts NCAM-mediated cell adhesion, induces neu- 
rite outgrowth from primary neurons [154], has neuroprotective 
effect [116], and increases intracellular Ca
2+ concentration ([Ca
2+]i,
[71]). These effects have been shown to be dependent on the intra-
cellular messengers also involved in the NCAM-induced signalling: 
FGFR, PLC, DAG, Akt, and MAPK thus rendering the peptide a 
convenient tool to mimic 'native' NCAM signalling. 
  Thus, we recently employed P2 to determine [Ca
2+]i-regulating 
mechanisms involved in NCAM-induced intracellular signalling, 
and their importance for NCAM-induced neurite outgrowth [71].
Using P2 as an NCAM ligand allowed us to monitor rapid NCAM-
induced Ca
2+-responses. This resulted in identifying previously 
unanticipated mechanisms of Ca
2+ homeostasis activated by NCAM 
and contributing to neuronal differentiation. 
  Other less well characterized small-weight ligands of NCAM 
include the peptides termed NBP10, P1B, and HBP. The NBP10 
peptide has been identified by screening a combinatorial synthetic 
peptide library with NCAM purified from postnatal day 10 rat 
brains [132]. This peptide binds NCAM Ig1 as demonstrated by 
NMR, and modulates cell aggregation and neurite outgrowth, in-
duced by NCAM homophilic binding. The neuritogenic effect of 
NBP10 is associated with the induction of Ca
2+ influx from the 
extracellular space [132]. The P1B peptide is a conserved sequence 
fragment of NCAM derived from the Ig1 module on the basis of 
structural studies [155]. This peptide presumably represents the Ig1 
contact area in an NCAM cis dimer and modulates physiological 
NCAM homophilic trans interaction in a dose-dependent manner 
[96]. The HBP peptide represents a continuous part of the heparin 
binding sequence in NCAM Ig2 module. The heparin-binding motif 
(HBM) in Ig2 has recently been shown to partially overlap with the 
Ig1-Ig2 contact site [89]. Thus, the peptide derived from the HBM 
site can be expected to affect/mimic cellular effects of NCAM de-
pendent on the Ig1-Ig2 interaction. Accordingly, the HBP peptide 
promotes neurite outgrowth from primary neurons. 
 The  in vitro effects of the aforementioned peptides suggest that 
they may have therapeutic applications; however, their in vivo ef-
fects are awaiting characterization. 
  The FGL peptide, EVYVVAENQQGKSKA, has been identi-
fied as part of the NCAM binding site for the D2-D3 region of the 
FGFR ectodomain [72]. In vitro, FGL binds to and phosphorylates 
FGFR [72] and increases neurite outgrowth and survival in primary 
neurons [72, 108].The effects of the FGL peptide depend on activa-
tion of FGFR and the MAPK and PI3K intracellular signalling 
pathways, which also are triggered by the NCAM ligation to FGFR. 
Thus, FGL mimics NCAM heterophilic binding to FGFR and can 
be considered as an NCAM-derived agonist of FGFR. This suggests 
wide opportunities for the peptide to be used both as a tool to study 
NCAM-initiated FGFR-mediated signalling, and as a pharmacol-
ogical compound mimicking in vivo effects of NCAM-induced 
FGFR activation. Indeed, a number of studies report stimulatory 
effects of FGL on synaptogenesis and memory consolidation [17], 
survival of hippocampal neurons after ischemic insult [153], and 
early postnatal sensorimotor development and social memory reten-
tion [144]. Recently, FGL also was shown to strongly reduce signs 
of -amyloid-induced neuropathology and cognitive impairment in 
rats [77]. 
  Interestingly, when assessed using surface plasmon resonance 
analysis, only a double NCAM F3,1-2 module bound to FGFR, but 
not to the F3,2 module alone [72]. This might mean that the F3,1 
module of NCAM also possessed the FGFR-binding site and thus 
contributed to the NCAM-FGFR interaction. This hypothesis has 
been tested by Anderson et al. [3], who have identified a peptide in 
the F3,1 module of NCAM (FRM) simulating FGFR activation, as 
well as FGFR-dependent neurite outgrowth and cell survival. The 
authors suggested that FRM might represent part of an FGFR acti-
vation site of NCAM and may have useful therapeutic applications. Pharmacology of Cell Adhesion Molecules of the Nervous System  Current Neuropharmacology, 2007, Vol. 5, No. 4    263
CONCLUSIONS AND PROSPECTS 
  Recent advances in characterizing human and other species 
genomes lead to cloning of a great number of new cell adhesion 
molecules (see e.g. [178]). It is now widely recognized that these 
molecules play major roles in almost every physiological and 
pathological process in multicellular organisms. It is therefore of 
immense importance to develop reliable pharmacological tools to 
study specific aspects of CAM functions. However, several intrinsic 
properties of CAMs make this task particularly challenging. Ex-
tracellularly, CAMs are in most cases involved in multiple and 
relatively low affinity interactions with themselves and with other 
CAMs and/or cell surface receptors, and the majority of CAMs 
does not possess any intrinsic enzymatic activity. The first pharma-
cological tools developed were antibodies targeting specific CAM 
epitopes. The second generation tools were recombinantly produced 
protein fragments (modules). Both approaches have a major draw-
back, the antibodies and the recombinant fragments are relatively 
large, unstable proteins, which makes it particularly difficult to use 
them for in vivo studies. The third, peptide-based, generation of 
pharmacological tools came along with the progress in our under-
standing of the structural basis of CAM-mediated cell adhesion 
allowing structure-based design of CAM mimetic peptides. The 
peptide ligands of CAMs can target particular regions of the com-
plex CAM interaction sites and induce specific signalling pathways, 
thereby allowing one to mimic specific aspects of CAM functions. 
In addition, these peptide mimetics are potential therapeutic agents. 
The therapeutic use of peptides is believed to be limited by their 
generally poor penetration through the blood-brain barrier (BBB). 
However, a recent study [144] indicates that a peptide from the 
NCAM binding site for FGFR, FGL, rapidly penetrates into the 
blood and cerebrospinal fluid after both intranasal and subcutane-
ous administration and remains detectable in the fluids for up to 5 
hours. In addition, modifications of the peptides can be made to 
facilitate crossing the BBB. Such modifications may include, for 
example, conjugation of the two peptides, where the first represents 
an 'active' sequence, and the second is known to cross the BBB by 
binding to appropriate 'carrier' receptors, such as megalin or LRP. 
Since peptides derived from low-affinity binding sites are by de-
fault the low-affinity ligands, the next step in developing CAM-
targeted pharmacological tools will be the generation of low mo-
lecular weight non-peptide molecules with high-affinity binding 
properties. The structural basis of cell adhesion is a rapidly devel-
oping field, and the latter probably may be achieved through ho-
mology modelling and molecular docking. 
ABBREVIATIONS 
2-AG =  2-arachidonoyl  glycerol 
AA =  Arachidonic  acid 
(N)CAM  =  (Neural) cell adhesion molecule 
CaMK =  Calcium-calmodulin  kinase 
CREB  =  Cyclic AMP response element binding protein 
Dab1 =  Disabled  1 
DAG =  Diacylglycerol 
ECM =  Extracellular  matrix 
ERK =  Extracellular  signal-regulated  kinase 
F3  =  Fibronectin type III 
FGFR  =  Fibroblast growth factor receptor 
GAP-43 =  Growth-associated  protein-43 
GPI =  Glycosylphosphatidyl  inositol 
Ig =  Immunoglobulin  (like) 
IP3 =  Inositoltrisphosphate 
LTP =  Long-term  potentiation 
MAPK  =  Mitogen activated protein kinase 
MASA  =  Mental retardation, aphasia, shuffling gait  
   (syndrome) 
MEK =  MAPK/ERK  kinase 
NP-1 =  Neuropilin-1 
NSCC  =  Non-selective cation channel 
PAK =  p21-activated  kinase 
PDK =  Phosphoinositide-dependent protein kinase 
PI3K =  Phosphatidylinositol  3-kinase 
PKC  =  Protein kinase C 
PLC =  Phospholipase  C 
PP1  =  Serine/threonine protein phosphatase 1
PSA =  Polysialic  acid 
RTK  =  Receptor tyrosine kinase 
SP1  =  Spastic paraplegia type 1 
TRP  =  Transient receptor potential (channel) 
(channel) 
VDCC =  Voltage-dependent  Ca
2+ channel 
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